Stifel Financial Corp cut its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 15.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 80,569 shares of the exchange traded fund’s stock after selling 14,837 shares during the quarter. Stifel Financial Corp owned approximately 0.16% of SPDR S&P Biotech ETF worth $6,975,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Captrust Financial Advisors lifted its holdings in shares of SPDR S&P Biotech ETF by 126.2% during the third quarter. Captrust Financial Advisors now owns 1,192 shares of the exchange traded fund’s stock valued at $103,000 after acquiring an additional 665 shares during the period. Ballentine Partners LLC bought a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at $121,000. Bingham Osborn & Scarborough LLC bought a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at $216,000. Northstar Asset Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at $217,000. Finally, National Planning Corp bought a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at $211,000.

Shares of SPDR S&P Biotech ETF (XBI) traded down $1.44 during midday trading on Thursday, hitting $81.48. The company’s stock had a trading volume of 3,717,800 shares, compared to its average volume of 4,242,237. SPDR S&P Biotech ETF has a 12 month low of $58.66 and a 12 month high of $88.98.

TRADEMARK VIOLATION WARNING: This piece was published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.watchlistnews.com/stifel-financial-corp-has-6-98-million-holdings-in-spdr-sp-biotech-etf-xbi/1764144.html.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.